DK1968635T3 - Sammensætninger og fremgangsmåder med og anvendelser af ikke-naturlige aminosyrer og polypeptider - Google Patents
Sammensætninger og fremgangsmåder med og anvendelser af ikke-naturlige aminosyrer og polypeptider Download PDFInfo
- Publication number
- DK1968635T3 DK1968635T3 DK06848566.3T DK06848566T DK1968635T3 DK 1968635 T3 DK1968635 T3 DK 1968635T3 DK 06848566 T DK06848566 T DK 06848566T DK 1968635 T3 DK1968635 T3 DK 1968635T3
- Authority
- DK
- Denmark
- Prior art keywords
- amino acid
- natural amino
- polypeptide
- amino acids
- alkylene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Claims (11)
1. Polypeptid eller salt deraf, indeholdende mindst en forbindelse udvalgt fra gruppen bestående af:
hvor hvert Ra uafhængigt er udvalgt fra gruppen bestående af H, halogen, alkyl, -N02, - CN, substitueret alkyl, -N(R')2, -C(0)kR', -C(0)N(R')2, -OR' og -S(0)kR', hvor k er 1,2 eller 3; M er H eller -CH2R5; Ri er H, en aminobeskyttelsesgruppe, harpiks, aminosyre, polypeptid eller polynukleotid; R2 er OH, en esterbeskyttelsesgruppe, harpiks, aminosyre, polypeptid eller polynukleotid; R5 er L-X, hvor X er en polymer omfattende alkyl, alkenyl, alkynyl, alkoxy, alkylalkoxy, polyalkylenoxid, aryl, heteroaryl, alkaryl eller aralkyl; og L eventuelt, og når det er til stede, er en linker udvalgt fra gruppen bestående af alkylen, alkenylen, -O-, -0-(alkylen)-,-(alkylen)-0-, -C(O)-, -C(0)-(alkylen)-, -(alkylen)-C(O)-, -C(0)N(R')-, -C(0)N(R')-(alkylen)-, -(alkylen)-C(0)N(R'), -0C(0)N(R')-, -0C(0)N(R')-(alkylen)-, -(alkylen)-0C(0)N(R')-, -N(R')C(0)-, -NR’C(0)-(alkylen)-, -(alkylen)-NR’C(O)-, -S-, -S-(alkylen)-, -S(0)k- hvor k er 1, 2 eller 3, -S(0)k(alkylen)-, -C(S)-, -C(S)-(alkylen)-, - CSN(R')-, -CSN(R')-(alkylen)-, -N(R')CO-(alkylen)-, -N(R')C(0)0-, -(alkylen)-ON=CR'-, -(alkylen)-C(0)NR'-(alkylen)-, -(alkylen)-S(0)k-(alkylen eller substitueret alkylen)-S-, -(alkylen)-S-S-, -S(0)kN(R>, -N(R')C(0)N(R')-, -N(R')C(S)N(R')-, - N(R')S(0)kN(R')-, -N(R')-N=, -C(R')=N-, -C(R')=N-N(R')-, -C(R')=N-N=, -C(R')2-N=N- og -C(R')2-N(R')-N(R')-; og hvert R' uafhængigt er H, alkyl eller substitueret alkyl; hvor forbindelsen er udvalat fra aruDoen:
2. Forbindelse ifølge krav 1, hvor polymeren omfatter polyalkylenoxid.
3. Forbindelse ifølge krav 1, hvor polymeren omfatter -[(alkylen)-O-(hydrogen eller alkyl)]x, hvor x er fra 20-10.000.
4. Forbindelse ifølge krav 1, hvor polymeren er m-PEG med en molekylvægt, der ligger i området fra ca. 2 til ca. 40 KDa.
5. Fremgangsmåde til fremstilling af en forbindelse indeholdende mindst en ikke-naturlig aminosyre udvalgt fra gruppen bestående af:
hvor forbindelsen er dannet af en reduktiv alkylering af en aromatisk amino-enhed på mindst en ikke-naturlig aminosyre med mindst en reaktant omfat tende mindst en aldehydenhed, hvor R-ι, R2, R5, Ra og M er som defineret i krav 1; hvor den i det mindste ene ikke-naturliae aminosvre er udvalgt fra en gruppe:
6. Fremgangsmåde ifølge krav 5, hvorved polymeren omfatter polyalkylenox-id eller et substitueret polyalkylenoxid.
7. Fremgangsmåde ifølge krav 5, hvorved polymeren omfatter -[(alkylen eller substitueret alkyien)-0-(hydrogen, alkyl, eller substitueret alkyl)]x, hvor x er fra 20-10.000.
8. Fremgangsmåde ifølge krav 5, hvorved polymeren er m-PEG med en molekylvægt, der ligger i området fra ca. 2 til ca. 40 KDa.
9. Fremgangsmåde ifølge krav 5, hvorved den i det mindste ene aldehydenhed har strukturen, der svarer til :
hvor: R5 er som defineret i krav 1.
10. Fremgangsmåde ifølge krav 5, hvorved den ikke-naturlige aminosyre inkorporeres ved anvendelse af et translationssystem.
11. Fremgangsmåde ifølge krav 5, hvorved den ikke-naturlige aminosyre inkorporeres i polypeptidet ved anvendelse af et translationssystem og en post-translationsmodifikationssystem.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74304005P | 2005-12-14 | 2005-12-14 | |
US74304105P | 2005-12-14 | 2005-12-14 | |
PCT/US2006/047822 WO2007070659A2 (en) | 2005-12-14 | 2006-12-13 | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1968635T3 true DK1968635T3 (da) | 2014-12-15 |
Family
ID=38163532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06848566.3T DK1968635T3 (da) | 2005-12-14 | 2006-12-13 | Sammensætninger og fremgangsmåder med og anvendelser af ikke-naturlige aminosyrer og polypeptider |
Country Status (14)
Country | Link |
---|---|
US (6) | US20080317670A1 (da) |
EP (1) | EP1968635B1 (da) |
JP (1) | JP2009519942A (da) |
KR (2) | KR101423898B1 (da) |
CN (2) | CN105384807A (da) |
AU (1) | AU2006326404B2 (da) |
CA (2) | CA2882445A1 (da) |
DK (1) | DK1968635T3 (da) |
ES (1) | ES2529065T3 (da) |
HK (1) | HK1123194A1 (da) |
IL (1) | IL209386A (da) |
NZ (2) | NZ568578A (da) |
SG (2) | SG10201405661QA (da) |
WO (1) | WO2007070659A2 (da) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050287639A1 (en) | 2004-05-17 | 2005-12-29 | California Institute Of Technology | Methods of incorporating amino acid analogs into proteins |
MX2007007590A (es) | 2004-12-22 | 2007-12-10 | Ambrx Inc | Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos. |
CN101400646A (zh) | 2005-11-08 | 2009-04-01 | Ambrx公司 | 用于修饰非天然氨基酸和非天然氨基酸多肽的促进剂 |
CN105384807A (zh) | 2005-12-14 | 2016-03-09 | Ambrx公司 | 含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途 |
AU2006332809A1 (en) * | 2005-12-30 | 2007-07-12 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
SI1999259T1 (sl) | 2006-03-03 | 2014-11-28 | California Institute Of Technology | Usmerjeno vključevanje amino kislin v molekule |
AU2012203737B2 (en) * | 2006-09-08 | 2014-06-19 | Ambrx, Inc. | Modified human plasma polypeptide or Fc scaffolds and their uses |
AU2007292903B2 (en) | 2006-09-08 | 2012-03-29 | Ambrx, Inc. | Modified human plasma polypeptide or Fc scaffolds and their uses |
KR101476472B1 (ko) | 2007-03-30 | 2015-01-05 | 암브룩스, 인코포레이티드 | 변형된 fgf-21 폴리펩티드 및 그 용도 |
NZ584825A (en) * | 2007-11-20 | 2013-03-28 | Ambrx Inc | Modified insulin polypeptides and their uses |
WO2010096394A2 (en) | 2009-02-17 | 2010-08-26 | Redwood Biosciences, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
NZ596283A (en) | 2009-05-11 | 2013-08-30 | Pfenex Inc | Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein |
WO2011017835A1 (en) * | 2009-08-11 | 2011-02-17 | Nanjing University | Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
MX346786B (es) | 2010-08-17 | 2017-03-31 | Ambrx Inc | Polipeptidos de relaxina modificados y sus usos. |
CN101967113B (zh) * | 2010-09-14 | 2012-08-22 | 北京欧凯纳斯科技有限公司 | 3-Alloc胺基-3-(3-硝基-4-氟苯基)丙酸及其制备方法 |
CN101962349B (zh) * | 2010-09-15 | 2012-08-22 | 北京欧凯纳斯科技有限公司 | 3-Boc胺基-3-(3-硝基-4-氟苯基)丙酸及其制备方法 |
CN101985432B (zh) * | 2010-09-15 | 2012-02-22 | 北京欧凯纳斯科技有限公司 | 3-Fmoc胺基-3-(3-硝基-4-氟苯基)丙酸及其制备方法 |
PT2637694T (pt) * | 2010-11-12 | 2021-05-05 | Nektar Therapeutics | Conjugados de uma fração de il-2 e um polímero |
AU2012205301B2 (en) | 2011-01-14 | 2017-01-05 | Redwood Bioscience, Inc. | Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
CN102614525A (zh) * | 2011-02-01 | 2012-08-01 | 复旦大学 | 一种蛋白介导的脑靶向基因递释***及其用途 |
US20140140962A1 (en) * | 2011-04-29 | 2014-05-22 | The Research Foundation Of State University Of New York | Viruses modified with unnatural moieties and methods of use thereof |
WO2013068874A1 (en) * | 2011-11-11 | 2013-05-16 | Pfizer Inc. | Antibody-drug conjugates |
WO2013130913A1 (en) * | 2012-02-29 | 2013-09-06 | Ambrx, Inc. | Interleukin-10 polypeptide conjugates and their uses |
AU2013270684B2 (en) | 2012-06-08 | 2018-04-19 | Sutro Biopharma, Inc. | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use |
DK2863955T3 (da) | 2012-06-26 | 2017-01-23 | Sutro Biopharma Inc | Modificerede fc-proteiner, der omfatter stedsspecifikke ikke-naturlige aminosyrerester, konjugater heraf, fremgangsmåder til fremstilling heraf og fremgangsmåder til anvendelse heraf |
EP2887965A1 (en) | 2012-08-22 | 2015-07-01 | ImmunoGen, Inc. | Cytotoxic benzodiazepine derivatives |
EP4074728A1 (en) | 2012-08-31 | 2022-10-19 | Sutro Biopharma, Inc. | Modified peptides comprising an azido group |
WO2014153002A1 (en) | 2013-03-14 | 2014-09-25 | The California Institute For Biomedical Research | Bispecific antibodies and uses thereof |
ES2865473T3 (es) | 2013-07-10 | 2021-10-15 | Sutro Biopharma Inc | Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso |
AU2014317884B2 (en) | 2013-09-09 | 2017-09-07 | Canimguide Therapeutics Ab | Immune system modulators |
WO2015054658A1 (en) | 2013-10-11 | 2015-04-16 | Sutro Biopharma, Inc. | Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use |
EP3057994B1 (en) | 2013-10-15 | 2020-09-23 | The Scripps Research Institute | Peptidic chimeric antigen receptor t cell switches and uses thereof |
KR102637699B1 (ko) | 2014-10-24 | 2024-02-19 | 브리스톨-마이어스 스큅 컴퍼니 | 변형된 fgf-21 폴리펩티드 및 그의 용도 |
ES2853582T3 (es) | 2015-03-06 | 2021-09-16 | Canimguide Therapeutics Ab | Moduladores del sistema inmune y composiciones |
WO2016154621A1 (en) | 2015-03-26 | 2016-09-29 | The California Institute For Biomedical Research | SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF |
EP3283113A4 (en) | 2015-04-15 | 2018-12-05 | The California Institute for Biomedical Research | Optimized pne-based chimeric receptor t cell switches and uses thereof |
GB201512372D0 (en) * | 2015-07-15 | 2015-08-19 | Nuclera Nucleics Ltd | Novel method |
EP3407917A1 (en) | 2016-01-27 | 2018-12-05 | Sutro Biopharma, Inc. | Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates |
AU2017257504A1 (en) | 2016-04-26 | 2018-10-25 | R.P. Scherer Technologies, Llc | Antibody conjugates and methods of making and using the same |
WO2018075807A1 (en) | 2016-10-19 | 2018-04-26 | California Institute For Biomedical Research | Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof |
SG11201907209QA (en) | 2017-02-08 | 2019-09-27 | Bristol Myers Squibb Co | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof |
RS65370B1 (sr) | 2017-06-02 | 2024-04-30 | Ambrx Inc | Metode i kompozicije za unapređenje proizvodnje proteina koji sadrže neprirodne aminokiseline |
BR112020008733A2 (pt) | 2017-11-02 | 2020-11-03 | University Of Iowa Research Foundation | método de resgate de códons de parada através de reatribuição genética com ace-trna |
CN108319816B (zh) * | 2018-02-27 | 2021-04-23 | 广州大学 | 一种基于基因通路识别小分子核糖核酸的方法 |
AU2019263303A1 (en) * | 2018-05-01 | 2020-12-24 | Ambrx, Inc. | A method for optimizing antibody expression |
CN110763530B (zh) * | 2018-07-27 | 2021-11-02 | 中国科学院上海有机化学研究所 | 对硒代半胱氨酸进行修饰的方法及其应用 |
CN111208299B (zh) * | 2018-11-21 | 2021-05-28 | 中国科学院大连化学物理研究所 | 一种交联肽段定性定量分析方法 |
CN111229188B (zh) * | 2018-11-28 | 2022-03-29 | 天津大学 | 糖肽类抗生素功能化磁性复合材料及其制备方法和应用 |
US11714072B2 (en) * | 2019-03-28 | 2023-08-01 | Honeywell International Inc. | Reagent compositions and method for Karl Fischer titration |
CN110609078B (zh) * | 2019-09-20 | 2022-03-11 | 南京谱利健生物技术有限公司 | 一种检测蛋白磷酸化和乙酰氨基葡萄糖化关联作用的方法 |
CN112618711B (zh) * | 2019-09-24 | 2023-09-29 | 华南理工大学 | 一种猪口服接种疫苗纳米复合佐剂及其制备方法与应用 |
US20230095053A1 (en) | 2020-03-03 | 2023-03-30 | Sutro Biopharma, Inc. | Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use |
JP2023530235A (ja) * | 2020-06-03 | 2023-07-14 | フェス・セラピューティクス,インコーポレーテッド | 個別化された処置方法のための製剤 |
WO2022002022A1 (zh) * | 2020-06-29 | 2022-01-06 | 北京拓界生物医药科技有限公司 | 一种放射性核素标记物及其应用 |
CN115093376A (zh) * | 2022-04-19 | 2022-09-23 | 北京大学 | 一种双/多重功能的非天然氨基酸及其偶联物和应用 |
CN115340615B (zh) * | 2022-08-12 | 2023-05-02 | 同济大学 | 一种基于环糊精-氨基酸的荧光分子及其合成方法与应用 |
WO2024077277A1 (en) | 2022-10-07 | 2024-04-11 | Ambrx, Inc. | Drug linkers and antibody conjugates thereof |
CN117101598B (zh) * | 2023-10-24 | 2024-03-15 | 南昌航空大学 | 一种钼基吸附材料的制备方法及其产品和应用 |
Family Cites Families (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US3869273A (en) * | 1971-04-29 | 1975-03-04 | Dow Chemical Co | Compositions and method for altering plant growth with an alkylenebisdithiocarbamatic complex |
GB1366554A (en) * | 1972-03-06 | 1974-09-11 | Science Union & Cie | Phenylalanine derivatives and a process for their preparation |
US4289872A (en) * | 1979-04-06 | 1981-09-15 | Allied Corporation | Macromolecular highly branched homogeneous compound based on lysine units |
FR2504010B1 (fr) * | 1981-04-15 | 1985-10-25 | Sanofi Sa | Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation |
US4551433A (en) * | 1981-05-18 | 1985-11-05 | Genentech, Inc. | Microbial hybrid promoters |
JPS57206622A (en) * | 1981-06-10 | 1982-12-18 | Ajinomoto Co Inc | Blood substitute |
US4485045A (en) * | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
DE3374837D1 (en) * | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
US4511503A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4511502A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4512922A (en) * | 1982-12-22 | 1985-04-23 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
CA1341302C (en) | 1983-02-22 | 2001-10-09 | Rae Lyn Burke | Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein |
US5089398A (en) * | 1983-02-22 | 1992-02-18 | Chiron Corporation | Enhanced yeast transcription employing hybrid GAPDH promoter region constructs |
US4876197A (en) | 1983-02-22 | 1989-10-24 | Chiron Corporation | Eukaryotic regulatable transcription |
US4755465A (en) * | 1983-04-25 | 1988-07-05 | Genentech, Inc. | Secretion of correctly processed human growth hormone in E. coli and Pseudomonas |
US4859600A (en) * | 1983-04-25 | 1989-08-22 | Genentech, Inc. | Recombinant procaryotic cell containing correctly processed human growth hormone |
US4544545A (en) * | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
US4689406A (en) * | 1983-08-10 | 1987-08-25 | Amgen | Enhancement of microbial expression of polypeptides |
ATE59966T1 (de) * | 1983-09-26 | 1991-02-15 | Ehrenfeld Udo | Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr. |
US4880734A (en) * | 1984-05-11 | 1989-11-14 | Chiron Corporation | Eukaryotic regulatable transcription |
EP0480480A3 (en) | 1984-05-11 | 1992-06-10 | Chiron Corporation | Enhanced yeast transcription employing hybrid promoter region constructs |
US4542225A (en) * | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
US4738921A (en) * | 1984-09-27 | 1988-04-19 | Eli Lilly And Company | Derivative of the tryptophan operon for expression of fused gene products |
US4659839A (en) * | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
US4837148A (en) * | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
JPS61243018A (ja) | 1985-04-18 | 1986-10-29 | Taisho Pharmaceut Co Ltd | 真菌症治療剤 |
EP0206448B1 (en) * | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US4680338A (en) * | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
US4699784A (en) * | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
US5186933A (en) * | 1986-12-30 | 1993-02-16 | Baylor College Of Medicine | Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
ATE103333T1 (de) | 1987-03-23 | 1994-04-15 | Zymogenetics Inc | Hohe proteinsyntheserate in hefe. |
US5229490A (en) * | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
US5080891A (en) * | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
US4929555A (en) * | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
US4904584A (en) * | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
CA1340772C (en) * | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
US5674706A (en) * | 1988-05-06 | 1997-10-07 | Chiron Corporation | High level expression of proteins in yeast |
FR2631974B1 (fr) * | 1988-05-31 | 1992-12-11 | Agronomique Inst Nat Rech | Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes |
US6780613B1 (en) * | 1988-10-28 | 2004-08-24 | Genentech, Inc. | Growth hormone variants |
WO1990004788A1 (en) * | 1988-10-28 | 1990-05-03 | Genentech, Inc. | Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
AU649217B2 (en) | 1988-11-18 | 1994-05-19 | Regents Of The University Of California, The | Method for site-specifically incorporating unnatural amino acids into proteins |
EP0401384B1 (en) * | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
US4902502A (en) * | 1989-01-23 | 1990-02-20 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
US5324844A (en) * | 1989-04-19 | 1994-06-28 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5122614A (en) * | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5162601A (en) * | 1989-11-22 | 1992-11-10 | The Upjohn Company | Plant potyvirus expression vector with a gene for protease |
US5364840A (en) | 1989-12-05 | 1994-11-15 | Vical, Inc. | Synthetic calcitonin peptides |
EP0450480B1 (en) * | 1990-04-06 | 1995-06-21 | The Administrators of The Tulane Educational Fund | Somatostatin Analogues |
US5219564A (en) * | 1990-07-06 | 1993-06-15 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
CA2018801C (en) | 1990-06-12 | 2000-08-22 | Pierre Louis Beaulieu | Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus |
FR2664905B1 (fr) * | 1990-07-18 | 1994-08-12 | Agronomique Inst Nat Rech | Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus. |
WO1992001800A1 (en) * | 1990-07-20 | 1992-02-06 | Chiron Corporation | Method for integrative transformation of yeast using dispersed repetitive elements |
WO1992004363A1 (en) * | 1990-09-04 | 1992-03-19 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of insulin-like growth factor-1 in methylotrophic yeast cells |
EP0513332A4 (en) * | 1990-11-14 | 1993-03-17 | Cargill, Incorporated | Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
US5252714A (en) * | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
EP0564531B1 (en) * | 1990-12-03 | 1998-03-25 | Genentech, Inc. | Enrichment method for variant proteins with altered binding properties |
US5231178A (en) * | 1991-01-16 | 1993-07-27 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Method for the purification of intact, correctly-folded insulin-like growth factor-1 |
DE4107857A1 (de) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5595732A (en) * | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
US6126944A (en) * | 1991-04-26 | 2000-10-03 | The United States Of America As Represented By The Department Of Health And Human Services | Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus |
US5281698A (en) * | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
US5290686A (en) * | 1991-07-31 | 1994-03-01 | The United States Of America As Represented By The Department Of Health And Human Services | Expression of influenza a M2 protein in baculovirus |
US5516657A (en) * | 1992-05-11 | 1996-05-14 | Cambridge Biotech Corporation | Baculovirus vectors for expression of secretory and membrane-bound proteins |
ZA933926B (en) * | 1992-06-17 | 1994-01-03 | Amgen Inc | Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules |
US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
CA2110543A1 (en) | 1992-12-09 | 1994-06-10 | David E. Wright | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
NZ250375A (en) * | 1992-12-09 | 1995-07-26 | Ortho Pharma Corp | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives |
US5532142A (en) * | 1993-02-12 | 1996-07-02 | Board Of Regents, The University Of Texas System | Method of isolation and purification of fusion polypeptides |
IL104734A0 (en) * | 1993-02-15 | 1993-06-10 | Univ Bar Ilan | Bioactive conjugates of cellulose with amino compounds |
US5762939A (en) * | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
US5643575A (en) * | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5491076A (en) * | 1993-11-01 | 1996-02-13 | The Texas A&M University System | Expression of foreign genes using a replicating polyprotein producing virus vector |
US5605792A (en) * | 1993-11-04 | 1997-02-25 | The Ohio State University Research Foundation | Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic |
US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
JP3090586B2 (ja) * | 1994-03-15 | 2000-09-25 | 片倉工業株式会社 | システインプロテアーゼ遺伝子欠損バキュロウイルスおよびその製造法並びにこれを利用する有用タンパク質の製造法 |
US5473034A (en) * | 1994-03-18 | 1995-12-05 | Hyogo Prefectural Government | Method for producing protein-synthetic polymer conjugate and said conjugate produced thereby |
US5629384A (en) * | 1994-05-17 | 1997-05-13 | Consiglio Nazionale Delle Ricerche | Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces |
FR2722210B1 (fr) * | 1994-07-08 | 1996-08-14 | Rhone Poulenc Rorer Sa | Nouvelles streptogramines et procede de preparation de streptogramines par mutasynthese |
US5650234A (en) * | 1994-09-09 | 1997-07-22 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
US5824784A (en) * | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
WO1996041813A2 (en) * | 1994-11-09 | 1996-12-27 | Offord Robin E | Functionalized polymers for site-specific attachment |
US5681928A (en) * | 1994-12-16 | 1997-10-28 | The Salk Institute For Biological Studies | Betides and methods for screening peptides using same |
US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
FR2732035B1 (fr) * | 1995-03-23 | 1997-05-30 | Agronomique Inst Nat Rech | Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede |
NZ308772A (en) * | 1995-05-17 | 1999-04-29 | Du Pont | Recombinant baculovirus insecticides |
US5672662A (en) * | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
EA001001B1 (ru) * | 1995-09-11 | 2000-08-28 | Дайити Фармасьютикал Ко., Лтд. | Производные пептидов |
US5705522A (en) * | 1995-09-15 | 1998-01-06 | Compagnie De Developpement Aguettant S.A. | Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors |
US5861279A (en) * | 1996-01-17 | 1999-01-19 | Schering Corporation | Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists |
US5980948A (en) * | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
DE69739319D1 (de) * | 1996-12-13 | 2009-04-30 | Novartis Vaccines & Diagnostic | Verfahren zur Expression von PDGF oder IGR Proteinen in Hefe |
US5990237A (en) * | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
EP0882736A1 (en) | 1997-06-02 | 1998-12-09 | Laboratoire Theramex S.A. | LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
US5965393A (en) * | 1997-07-01 | 1999-10-12 | National Institute Of Immunology | Method for enhancing foreign gene expression in baculovirus expression vector system |
EP1881005B1 (en) | 1997-07-14 | 2013-04-03 | Bolder Biotechnology, Inc. | Derivatives of G-CSF and related proteins |
HUP0003921A3 (en) * | 1997-07-31 | 2001-03-28 | Wyeth Corp | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4, pharmaceutical compositions comprising thereof and their use |
US6492421B1 (en) | 1997-07-31 | 2002-12-10 | Athena Neurosciences, Inc. | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6583139B1 (en) * | 1997-07-31 | 2003-06-24 | Eugene D. Thorsett | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6455550B1 (en) * | 1997-08-22 | 2002-09-24 | Hoffmann-La Roche Inc. | N-alkanoylphenylalanine derivatives |
US5989868A (en) * | 1997-09-12 | 1999-11-23 | The Board Of Regents Of The University Of Oklahoma | Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli |
WO1999016318A1 (en) * | 1997-09-26 | 1999-04-08 | Uab Research Foundation | Reduced antigenic cells and uses therefor |
US6449281B1 (en) * | 1997-09-30 | 2002-09-10 | Intel Corporation | Interface control of communication between a control processor and a digital signal processor |
US6004573A (en) * | 1997-10-03 | 1999-12-21 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
WO1999031124A1 (en) * | 1997-12-12 | 1999-06-24 | Novo Nordisk A/S | Cholic acid-based scaffolds for multidimensional molecular presentation of peptides |
SE9800550D0 (sv) * | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
PT1062201E (pt) | 1998-03-11 | 2005-02-28 | Searle & Co | Derivados halogenados de amidino-aminoacidos uteis como inibidores da sintase do acido nitrico |
US6168932B1 (en) * | 1998-07-13 | 2001-01-02 | Parker Hughes Institute | Recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system |
US6994986B2 (en) | 1999-03-17 | 2006-02-07 | The Board Of Trustees Of The Leland Stanford University | In vitro synthesis of polypeptides by optimizing amino acid metabolism |
CA2365668C (en) | 1999-03-17 | 2014-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system |
US6337191B1 (en) | 1999-03-22 | 2002-01-08 | The Board Of Trustees Of The Leland Stanford Junior University | Vitro protein synthesis using glycolytic intermediates as an energy source |
EP1226237A2 (en) * | 1999-08-31 | 2002-07-31 | Basf Aktiengesellschaft | Method of identifying inhibitors of cdc25 |
AU781839B2 (en) * | 1999-12-22 | 2005-06-16 | Nektar Therapeutics | Sterically hindered derivatives of water soluble polymers |
WO2002000216A1 (en) | 2000-06-28 | 2002-01-03 | Teva Pharmaceutical Industries Ltd. | Carvedilol |
US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
EP2796546B1 (en) | 2001-04-19 | 2017-08-09 | The Scripps Research Institute | Incorporation of unnatural amino acids |
DE60228954D1 (en) | 2001-05-03 | 2008-10-30 | Galileo Lab Inc | Pyruvatderivate |
US6608196B2 (en) | 2001-05-03 | 2003-08-19 | Galileo Pharmaceuticals, Inc. | Process for solid supported synthesis of pyruvate-derived compounds |
EP1434576A4 (en) | 2001-09-13 | 2006-03-29 | Kenneth E Miller | METHOD FOR RELIEVING PAIN |
KR100948532B1 (ko) * | 2001-11-07 | 2010-03-23 | 넥타르 테라퓨틱스 | 분지형 중합체 및 그의 공액체 |
MXPA04004809A (es) * | 2001-11-20 | 2004-08-11 | Pharmacia Corp | Conjugados de hormona de crecimiento humana modificada quimicamente. |
AU2002353485B2 (en) * | 2001-12-04 | 2009-01-15 | Ben Gurion University Of The Negev Research And Development Authority | Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
CN1293042C (zh) * | 2002-02-07 | 2007-01-03 | 远藤仁 | 芳香族氨基酸衍生物及其药物组合物 |
PT1578949E (pt) | 2002-10-16 | 2009-07-14 | Scripps Research Inst | Incorporação específica do local de cetoaminoácidos em proteínas |
AU2004233083B2 (en) * | 2003-04-17 | 2010-09-16 | The Scripps Research Institute | Expanding the eukaryotic genetic code |
WO2005014534A1 (en) * | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
WO2005035551A2 (en) * | 2003-10-08 | 2005-04-21 | Incyte Corporation | Inhibitors of proteins that bind phosphorylated molecules |
AU2005211385B2 (en) * | 2004-02-02 | 2008-12-11 | Ambrx, Inc. | Modified human growth hormone polypeptides and their uses |
EP1715895A2 (en) * | 2004-02-09 | 2006-11-02 | Pharmacia Corporation | Chemically-modified human growth hormone receptor antagonist conjugates |
US7618981B2 (en) * | 2004-05-06 | 2009-11-17 | Cytokinetics, Inc. | Imidazopyridinyl-benzamide anti-cancer agents |
MX2007007590A (es) * | 2004-12-22 | 2007-12-10 | Ambrx Inc | Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos. |
US20100130737A1 (en) * | 2005-02-18 | 2010-05-27 | Takeda Pharmaceutical Company Limited | Regulating Agent of GPR34 Receptor Function |
CN101400646A (zh) | 2005-11-08 | 2009-04-01 | Ambrx公司 | 用于修饰非天然氨基酸和非天然氨基酸多肽的促进剂 |
CN105384807A (zh) | 2005-12-14 | 2016-03-09 | Ambrx公司 | 含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途 |
AU2006332809A1 (en) | 2005-12-30 | 2007-07-12 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
-
2006
- 2006-12-13 CN CN201510634633.2A patent/CN105384807A/zh active Pending
- 2006-12-13 EP EP06848566.3A patent/EP1968635B1/en active Active
- 2006-12-13 SG SG10201405661QA patent/SG10201405661QA/en unknown
- 2006-12-13 AU AU2006326404A patent/AU2006326404B2/en not_active Ceased
- 2006-12-13 WO PCT/US2006/047822 patent/WO2007070659A2/en active Application Filing
- 2006-12-13 JP JP2008545828A patent/JP2009519942A/ja active Pending
- 2006-12-13 NZ NZ568578A patent/NZ568578A/en not_active IP Right Cessation
- 2006-12-13 US US12/096,009 patent/US20080317670A1/en not_active Abandoned
- 2006-12-13 DK DK06848566.3T patent/DK1968635T3/da active
- 2006-12-13 ES ES06848566.3T patent/ES2529065T3/es active Active
- 2006-12-13 SG SG201101823-1A patent/SG170116A1/en unknown
- 2006-12-13 CA CA2882445A patent/CA2882445A1/en not_active Abandoned
- 2006-12-13 NZ NZ595303A patent/NZ595303A/xx not_active IP Right Cessation
- 2006-12-13 CN CN200680046887.1A patent/CN101448512B/zh not_active Expired - Fee Related
- 2006-12-13 KR KR1020137021294A patent/KR101423898B1/ko not_active IP Right Cessation
- 2006-12-13 KR KR1020087014677A patent/KR101332875B1/ko not_active IP Right Cessation
- 2006-12-13 CA CA2631491A patent/CA2631491C/en not_active Expired - Fee Related
-
2007
- 2007-10-26 US US11/925,740 patent/US8153758B2/en not_active Expired - Fee Related
- 2007-10-26 US US11/925,732 patent/US8557781B2/en not_active Expired - Fee Related
- 2007-10-26 US US11/925,735 patent/US8399614B2/en not_active Expired - Fee Related
-
2009
- 2009-01-21 HK HK09100638.9A patent/HK1123194A1/xx not_active IP Right Cessation
-
2010
- 2010-11-17 IL IL209386A patent/IL209386A/en not_active IP Right Cessation
-
2012
- 2012-05-09 US US13/467,870 patent/US8865658B2/en not_active Expired - Fee Related
-
2013
- 2013-08-23 US US13/974,987 patent/US9586988B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1968635T3 (da) | Sammensætninger og fremgangsmåder med og anvendelser af ikke-naturlige aminosyrer og polypeptider | |
DK1828224T3 (da) | Sammensætninger indeholdende, fremgangsmåder indbefattende, og anvendelser af ikke-naturlige aminosyrer og polypeptider | |
US20090240029A1 (en) | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides | |
US20100098630A1 (en) | Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides | |
AU2013205030B2 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
AU2011253844B2 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
AU2012202615B2 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
MX2008007646A (es) | Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos |